medical dermatology society annual meeting thursday… annual meeting/2017 mds annual... · medical...

20
MEDICAL DERMATOLOGY SOCIETY ANNUAL MEETING THURSDAY, MARCH 2, 2017 HILTON ORLANDO 2017

Upload: vunhi

Post on 15-May-2018

217 views

Category:

Documents


1 download

TRANSCRIPT

MEDICAL DERMATOLOGY SOCIETYANNUAL MEETINGTHURSDAY, MARCH 2, 2017HILTON ORLANDO

2017

2

3

PRESIDENT’S LETTER

Dear Members of the MDS:

On behalf of the MDS Board of Directors, I would like to personally welcome you to the 2017 Medical Dermatology

Society Annual Meeting. It is an exciting time for the MDS; we continue to grow and remain ever adaptable, motivated,

and responsive to addressing the needs of our patients and to growing the field of medical dermatology.   At a time of

national and global change, the MDS is committed to sharing knowledge, facilitating collaborative opportunities, and

supporting the development of inspired dermatologists who will advance our specialty.

As in previous years, you will find the program to be comprehensive, informative, and relevant. The content of this

year’s meeting focuses on current, practical issues that physicians will encounter when diagnosing or treating

patients with complex medical dermatologic problems in the outpatient and inpatient setting. ‘Complex Medical

Dermatology Cases and Treatment Conundrums’ will be discussed by Drs. Jeffrey Callen, Alisa Femia and Lindy Fox.

This year’s Key Note on ‘Novel Therapeutic Agents for Cutaneous Malignancies’ will be given by Dr. Jennifer Choi

from Northwestern University. Drs. Robert Micheletti and Karolyn Wanat will present ‘Systematic Approaches to

Diagnosing Emerging Infectious Diseases’. I want to thank the members of the MDS Committees and Board who have

worked throughout the year to ensure a quality meeting. As always, we are grateful to Debbie Kovacs for her tireless

support of our organization every day.

In closing, I would like to thank each of your for attending the MDS Annual Meeting and bringing your expertise and

passion to our gathering. As leaders in the field of medical dermatology, you have the vision, knowledge, compassion,

and drive to help pave our way forward. You are truly our greatest asset and we could not accomplish what we do

without your support. Throughout this Annual Meeting and beyond, I ask you to stay engaged, be proactive, and

continue to shape the future of medical dermatology. 

If you have any questions regarding the upcoming meeting or other MDS activities, please do not hesitate to reach out

to me directly or to our administrative office.  Welcome to the 2017 Annual Meeting!

Sincerely,

Daniela Kroshinsky, MD, MPH

Medical Dermatology Society President

4

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Iowa Carver College of Medicine and the Medical Dermatology Society. The Carver College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Iowa Carver College of Medicine designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

HISTORY & MISSION

The MDS is made up of the thought leaders in clinical dermatology and the teachers of the next generation of practicing dermatologists. The MDS mission is to improve the care of patients whose skin diseases or therapies have substantial systemic consequences; foster research in medical dermatology and assure medical dermatology expertise in community and academic settings.

Members of the MDS represent the heart and soul of our specialty: medical dermatology. Founded in 1994, our members include Academicians, Private Practitioners and Resident Physicians who specialize in the care of patients with dermatologic diseases.

The Medical Dermatology Society (MDS) is a physician organization dedicated to:

• Advancing the understanding and treatment of serious dermatologic diseases through education and research.

• Exchanging advances in the field of medical dermatology.

• Promoting the training of dermatology residents, fellows and practitioners in the pathogenesis and treatment of complex dermatologic diseases.

This course is designed for physicians in the following specialties: Dermatology, Internal Medicine and Dermatopathology.

Session will encourage all participants of this activity to implement some of the new information and/or techniques into their practice. Encourage participants to change as a result of attending this activity.

In this educational program, we will address the following practice based on challenges and problems:

• Evidence and expert based treatment dilemmas for complex medical dermatology cases.

• Evidence based treatments for cutaneous malignancies and their associated adverse reactions.

• Evidence based treatments for emerging infections in hospitalized patients.

• Expert based discussion of clinical cases with high teaching value.

Demonstrate knowledge about established and evolving biomedical, clinical and cognate sciences and their application in patient care. Investigate and evaluate patient care practices, appraise and assimilate scientific evidence and improve practice of medicine.

Identify errors and hazards in care; understand and implement basic safety design principles; continually understand and measure quality of care in terms of structure, process and outcomes in relation to patient and community needs; design and test interventions to change processes and systems of care with the objective of improving quality.

Communicate, manage knowledge, mitigate error, and support decision making using information technology.

This activity will provide educational content aimed at closing the defined gap to result in improved knowledge, competence, and/or performance, which could result in improved patient outcomes.

TARGET AUDIENCE AND SYMPOSIUM DESCRIPTION AND LEARNING OBJECTIVES

University of Iowa JOINT PROVIDER STATEMENT

5

OFFICERS DANIELA KROSHINSKY, MD, MPHPresident2016-2018Massachusetts General Hospital, Harvard Medical School

LINDY FOX, MDPresident-Elect2016-2018University of California, San Francisco

MISHA ROSENBACH, MDSecretary-Treasurer2015-2018University of Pennsylvania

DIRECTORS

ADELA RAMBI CARDONES, MD2016-2021Duke University Medical Center

JONATHAN COTLIAR, MD2015-2020Science37

AMIT GARG, MD2013-2018Northwell Health

CARRIE KOVARIK, MD2012-2017University of Pennsylvania

NAVJEET SIDHU-MALIK, MD2014-2019Duke University Medical Center

MEMBERSHIP COMMITTEE

NAVJEET SIDHU-MAILK, MDChair2014-2019Duke University Medical Center

ADELA RAMBI CARDONES, MDCo-Chair2016-2021Duke University Medical Center

NICOLE FETT, MD 2014-2017Oregon Health and Sciences University

ARASH MOSTAGHIMI, MD, MPA, MPH2016-2019Brigham and Women’s Hospital, Harvard Medical School

GIDEON SMITH, MD2015-2018Massachusetts General Hospital, Harvard Medical School

FINANCE COMMITTEE

JONATHAN COTLIAR, MDChair2015-2020Science37

MILAN ANADKAT, MD2014-2017Washington University School of Medicine

JOSEPH F. MEROLA, MD2015-2018Brigham and Women’s Hospital, Harvard Medical School

VINOD NAMBUDIRI, MD2016-2019Grand Strand Medical Center

MISHA ROSENBACH, MDSecretary-Treasurer (ex-officio)2015-2018University of Pennsylvania

EDUCATION AND PROGRAMS COMMITTEE

CARRIE KOVARIK, MDChair2012-2017 University of Pennsylvania

AMIT GARG, MDCo-Chair2013-2018Northwell Health

BONNIE KOO, MD2016-2019Northwell Health

ROBERT MICHELETTI, MD2014-2017University of Pennsylvania

KANADE SHINKAI, MD, PHD2016-2019University of California, San Francisco

RUTH ANN VLEUGELS, MD, MPH2014-2017Brigham and Women’s Hospital, Harvard Medical School

KAROLYN WANAT, MD2015-2018University of Iowa Hospital & Clinics

KEVIN C. WANG, MD2015-2018Stanford University School of Medicine

XIAOLONG (ALAN) ZHOU, MD, MSC2015-2017 Northwestern University, Feinberg School of Medicine

2016-2017 MEDICAL DERMATOLOGY SOCIETYBOARD AND COMMITTEE MEMBERS

6

12:55 PM        INTRODUCTION AND WELCOME Daniela Kroshinsky, MD, MPH Associate Professor of Dermatology Director of Inpatient Dermatology, Director of Pediatric Dermatology Massachusetts General Hospital, Harvard Medical School                                               

1:00-2:00 PM ABSTRACT PRESENTATIONS Presiding: Carrie Kovarik, MD Associate Professor of Dermatology, Dermatopathology, and Infectious Diseases, University of Pennsylvania

1:00-1:15 PM Sweet syndrome: A retrospective clinical and histopathological analysis of 83 patients from a tertiary academic referral center Caroline Nelson, MD, University of Pennsylvania

1:15-1:30 PM Potential items for inclusion as classification criteria for discoid Lupus erythematosus (DLE): Results of a consensus exercise Scott Elman, MD, Brigham and Women’s Hospital, Harvard Medical School

1:30-1:45 PM Evaluation of emergency department utilization for dermatological conditions in the United States from 2010-2013 Daniel Bach, MD, MPH, Harvard Combined Dermatology Program

1:45-2:00 PM Gabapentin and pregabalin for the treatment of cutaneous lymphoma associated pruritus Auris Huen, MD, PharmD, University of Texas MD Anderson Cancer Center                                              

2:00-2:45 PM COMPLEX MEDICAL DERMATOLOGY CASES WITH TREATMENT CONUNDRUMS: EXPERT PANEL AND PARTICIPANT DISCUSSION Jeffrey Callen, MD Chief, Division of Dermatology, Professor of Medicine University of Louisville School of Medicine

Alisa N. Femia, MD Assistant Professor, Ronald O. Perelman Department of Dermatology Director, Inpatient Dermatology, Department of Dermatology New York University, Langone Medical Center

Lindy Fox, MD Associate Professor of Clinical Dermatology, Department of Dermatology University of California, San Francisco                                               

2:45-3:00 PM ABSTRACT VIEWING/BREAK                                              

3:00-3:45 PM KEYNOTE PRESENTATION Presiding: Xiaolong (Alan) Zhou, MD, MSc. Northwestern University, Feinberg School of Medicine

Novel Therapeutic Agents For Cutaneous Malignancies And Adverse Reactions Jennifer N. Choi, MD Associate Professor of Dermatology, Northwestern University, Feinberg School of Medicine Chief, Division of Oncodermatology, Robert H. Lurie Comprehensive Cancer Center 

2017 ANNUAL MEETING OF THE MEDICAL DERMATOLOGY SOCIETYTHURSDAY, MARCH 2, 2017

7

2017 ANNUAL MEETING OF THE MEDICAL DERMATOLOGY SOCIETYTHURSDAY, MARCH 2, 2017

3:45-4:30 PM EMERGING INFECTIOUS DISEASES TO REMEMBER IN HOSPITALIZED PATIENTS

PART I: Systematic Approach to the Differential Diagnosis Robert Micheletti, MD Assistant Professor of Medicine and Dermatology University of Pennsylvania

PART II: Practical Interactive Case Examples Using Systematic Approach Karolyn Wanat, MD Clinical Assistant Professor of Dermatology, Pathology, and Infectious Diseases University of Iowa Carver College of Medicine                                              

4:30-4:45 PM ABSTRACT VIEWING/BREAK                                              

4:45-5:45 PM SHINING PEARLS:  IMPORTANT LESSONS FROM GREAT CASES ABSTRACT SUBMISSIONS Presiding: Kevin C. Wang, MD, PhD Assistant Professor of Dermatology, Stanford University School of Medicine

4:45-5:00 PM Pityriasis rubra-like erythroderma secondary to phosphoinositide 3-kinase inhibition Anna Dewan, MD, Brigham and Women’s Hospital, Harvard Medical School

5:00-5:15 PM A case of near-fatal drug rash with eosinophilia and systemic symptoms (DRESS) successfully treated with the janus kinase inhibitor tofacitinib: Is DRESS a self-limited form of hypereosinophilic syndrome? Brett A. King, MD, PhD, Yale University

5:15-5:30 PM A case-based discussion of anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis Drew Kurtzman, MD, University of Arizona 5:30-5:45 PM Chronic malignant acanthosis nigricans Lauren Becker, MD, University of Minnesota                                               

5:45-5:55 PM 2017 LIFETIME ACHIEVEMENT AWARD

RUSSELL P. HALL, MD Professor and Chair Duke University School of Medicine

Presented by: Stephen I. Katz, MD, PhD, NIH, NIAMS

5:55-6:15 PM MDS BUSINESS MEETING AND MDS MENTORSHIP AWARDS ANNOUNCEMENT                                              

6:15-7:15 PM NETWORKING RECEPTION             

8

MEDICAL DERMATOLOGY SOCIETY

Lifetime Achievement Award Recipients

2017 RUSSELL P. HALL, MD Duke University Medical Center

2016 JEAN BOLOGNIA, MD Yale University School of Medicine

2015 WILLIAM JAMES, MD University of Pennsylvania

2014 LUIS A. DIAZ, MD University of North Carolina, Chapel Hill

2013 RICHARD D. SONTHEIMER, MD University of Utah Health Care

2012 GERALD G. KRUEGER, MD University of Utah Health Care

2011 JEFFREY P. CALLEN, MD University of Louisville School of Medicine

2010 VICTORIA P. WERTH, MD University of Pennsylvania 2009 HARLEY A. HAYNES, MD Brigham and Women’s Hospital

2008 KENNETH E. GREER, MD University of Virginia

2007 LEE T. NESBITT, JR., MD Louisiana State University Health Sciences Center

2006 SAMUEL MOSCHELLA, MD Lahey Hospital and Medical Center

2005 THOMAS T. PROVOST, MD Johns Hopkins Hospital

2004 IRWIN M. BRAVERMAN, MD Yale School of Medicine

9

RUSSELL P. HALL, MDDuke University Medical CenterProfessor and Chair

In Recognition of your Distinguished and Inspired

Research, Patient Care and Teaching in Medical Dermatology.

MEDICAL DERMATOLOGY SOCIETY presents the

2017 LIFETIME ACHIEVEMENT AWARD

10

2016 MDS SUSTAINING MEMBERS

A special THANK YOU to all who have generously contributed to the MDS!

Stephanie Frisch, MD Central Illinois Dermatology

Steven Gourlay, MD, PhD, MBA Principia Biopharma Inc.

Michael Heffernan, MD San Luis Dermatology and Laser Clinic

Anne Laumann, MBChB/MRCP (UK) Northwestern University, Feinberg School of Medicine

Jami Miller, MD Vanderbilt University Medical Center

Dedee Murrell, MA, BMBCh, MD St George Hospital, University of New South Wales

Marta Petersen, MD University of Utah

Arturo Saavedra, MD, PhD, MBA Massachusetts General Hospital

Kanade Shinkai, MD, PhD University of California, San Francisco

Campbell Stewart, MD Lake Washington Dermatology

Bruce Wintroub, MD University of California, San Francisco

John Zone, MD University of Utah

11

Thank You to Our Members for Their Generous Contributions To The Mentorship Program!

Murad Alam, MD, Northwestern University, Feinberg School of Medicine Sungat Grewal, BS, University of Pennsylvania William James, MD, University of Pennsylvania

A sincere Thank you to all members who have generously sponsored Medical Students/Residents/Post-Doctoral Fellows

Jean Bolognia, MDYale University School of Medicine

Jonathan Cotliar, MDScience 37

Peggy Crawford, MDKaiser Permanente

Nicole M. Fett, MDOregon Health & Science University

Joanna Harp, MDWeill Cornell Medical College

Harley Haynes, MDBrigham and Women’s Hospital

Michael Heffernan, MDSan Luis Dermatology and Laser Clinic

William James, MDUniversity of Pennsylvania

Carrie Kovarik, MDUniversity of Pennsylvania

Anne Laumann, MDNorthwestern University, Feinberg School of Medicine

Lela Lee, MDUniversity of Colorado

Joseph Merola, MDBrigham and Women’s Hospital, Harvard Medical School

Samuel Moschella, MDLahey Clinic Medical Center

Julia Nunley, MDVirginia Commonwealth University

Misha Rosenbach, MDUniversity of Pennsylvania

Arturo Saavedra, MD, PhD, MBAMassachusetts General Hospital

Kanade, Shinkai, MD, PhDUniversity of California, San Francisco

Robert Swerlick, MDEmory University School of Medicine

As of January 23, 2017

12

13

14

15

16

MEDICAL-DERMATOLOGY RESIDENCY PROGRAMDual Training

10 Years and Still Going Strong!

17

18

CMEBy attending the MDS Annual Meeting you are eligible to claim 4 AMA PRA Category 1 Credits.

Certificates will be MAILED directly to you by the University of Iowa to the address on your meeting registration.

Join us in Portland, Oregon

2017 MDS ABSTRACT SESSIONFriday, April 28 in conjunction with the SID ANNUAL MEETING

19

ANNUAL MEETINGof the

MEDICAL DERMATOLOGY SOCIETY

Thursday, March 2, 2017

Orlando, Florida

This program is supported in part by:

Abbvie Pharmaceutical

BioTek reMEDys

Lily U.S.A.

Valeant Pharmaceuticals North America

We gratefully acknowledge the financial support provided. Determination of educational content for this program and the selection of speakers are responsibilities of the

program director. Firms providing support did not have input in these areas.

Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with

any commercial interest.

Medical Dermatology Society526 Superior Avenue East, Suite 340

Cleveland, OH 44114P: 216.579.9300F: 216.579.9333

[email protected]

SAVE THEDATE

2018 MDS Annual MeetingThursday, February 15, 2018San Diego, California